Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 02.08.2022.

Biotechnology
Venture capital
Dot-com bubble
Initial public offering
Antibody
Corporation

@FlagshipPioneer shared
On Jul 28, 2022
Congratulations to @alltrna and @VesaliusTx for being included on @BusinessInsider's annual list of investor picks of the top biotech startups poised to take off in the next 12 months. #FlagshipFounded #biotech @AndrewE_Dunn @jesse_yeji https://t.co/WSzsuhmIFB
Open
Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs

Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs

Biotech investors look at hundreds of startups each year, trying to find the best new companies. Here are the privately held, venture-backed businesses they think will take off.

@BentheFidler shared
On Aug 2, 2022
"I’m trying to advocate for something that’s less common, because that’s what needs the advocacy." @NedPagliarulo talks with @DrSynbio about founder-led biotech, venture capital and the market’s retreat https://t.co/cA2e4iX3NJ
Open
Strand CEO on founder-led biotech, venture capital and the market’s retreat

Strand CEO on founder-led biotech, venture capital and the market’s retreat

Jake Becraft, founder and current chief of mRNA startup Strand Therapeutics, argues biotech would be healthier if more scientists and researchers lead the companies they start.

@BentheFidler shared
On Jul 28, 2022
Novartis-linked startup launches with technology designed to remove ‘destroy’ tags on helpful proteins https://t.co/oMJVkr7oeX by @realJacobBell $NVS #startups #biotech
Open
Novartis-linked startup launches with technology designed to remove ‘destroy’ tags on helpful proteins

Novartis-linked startup launches with technology designed to remove ‘destroy’ tags on helpful proteins

Vicinitas and its protein-stabilizing research have attracted $65 million from a group of investors that includes a16z, Deerfield and GV.

@adamfeuerstein shared
On Aug 2, 2022
Alexis Borisy, biotech’s ‘man of many hats,’ dons another https://t.co/r8dstAe1ZB via @ADeAngelis_bio
Open
Alexis Borisy, biotech’s ‘man of many hats,’ dons another

Alexis Borisy, biotech’s ‘man of many hats,’ dons another

IDRx is starting off with $122 million and two licensed drug candidates it plans to combine to create a treatment for gastrointestinal stromal tumors, or GIST.

@BentheFidler shared
On Aug 1, 2022
RT @bradloncar: There are a lot of disturbing allegations in this story. As a side note, I've never heard of a mansion described by the number of dishwashers it has? He "owns a seven-dishwasher waterfront mansion in Woodway." https://t.co/JcXrdqXJHq
Open
Clay Siegall built Seattle biotech firm Seagen into a $1.6B giant. Then the cops came calling

Clay Siegall built Seattle biotech firm Seagen into a $1.6B giant. Then the cops came calling

Seagen chief Clay Siegall quit after an arrest at his home. Now, records obtained by The Seattle Times show it wasn't the first time cops came.

@BentheFidler shared
On Jul 27, 2022
Versant partners with AbCellera to arm #startups with better antibodies https://t.co/FlQwUfpYnt by @NedPagliarulo $ABCL $LLY @VersantVentures
Open
Versant partners with AbCellera to arm startups with better antibodies

Versant partners with AbCellera to arm startups with better antibodies

The companies pitch their collaboration as a way to give young drugmakers backed by Versant a head start. “Our business is advanced by great ideas coming into the funnel,” said AbCellera’s ...

@BiotechWorld shared
On Aug 1, 2022
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects https://t.co/kbzLtYqrXq
Open
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects

Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects

Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects - read this article along with other careers information, tips and advice on ...

@ScottKirsner shared
On Jul 29, 2022
RT @BostonGlobeTech: Meet Tim Springer, a notable "weird-science guy" and one of small bunch of billionaires that the Greater Boston biotech industry has created. @ScottKirsner touches on his history with Moderna, his first startup, and his gongshi collection. https://t.co/bDPKsuPk1m
Open
This billionaire has quietly driven Boston’s biotech industry for decades

This billionaire has quietly driven Boston’s biotech industry for decades

He set in motion a series of events that created the company Moderna — and committed to being its first investor. But he still regularly rides his bike to work, and he “never viewed science ...